# SouthState Bank Corp: financial statements, quarterly

SSB · NYSE · CIK 764038 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ssb.md) · [Financials](/companies/ssb/financials.md) · [Filings](/companies/ssb/filings.md) · [Insiders](/companies/ssb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ssb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [161 d](/filings/0001558370-24-002302.md) | [173](/filings/0001558370-24-006602.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [29.8 d](/filings/0001104659-26-017884.md) | [38.5](/filings/0001558370-25-006162.md) | [40.5](/filings/0001558370-25-009936.md) | [43.4](/filings/0001104659-25-104685.md) | [43.2 d](/filings/0001104659-26-017884.md) | [32.2](/filings/0001104659-26-053548.md) | [67.0](/filings/0001104659-26-089026.md) | [74.7](/filings/0001193125-26-439976.md) | [67.7 d](/filings/0001104659-26-017884.md) | [65.6](/filings/0001104659-26-053548.md) | [69.0](/filings/0001104659-26-089026.md) | [66.5](/filings/0001193125-26-439976.md) |
| Net income | $m | [107 d](/filings/0001104659-26-017884.md) | [115](/filings/0001558370-25-006162.md) | [132](/filings/0001558370-25-009936.md) | [143](/filings/0001104659-25-104685.md) | [144 d](/filings/0001104659-26-017884.md) | [89.1](/filings/0001104659-26-053548.md) | [215](/filings/0001104659-26-089026.md) | [247](/filings/0001193125-26-439976.md) | [248 d](/filings/0001104659-26-017884.md) | [226](/filings/0001104659-26-053548.md) | [230](/filings/0001104659-26-089026.md) | [224](/filings/0001193125-26-439976.md) |
| Diluted EPS | $ per share | not reported | [1.50](/filings/0001558370-25-006162.md) | [1.73](/filings/0001558370-25-009936.md) | [1.86](/filings/0001104659-25-104685.md) | not reported | [0.87](/filings/0001104659-26-053548.md) | [2.11](/filings/0001104659-26-089026.md) | [2.42](/filings/0001193125-26-439976.md) | not reported | [2.28](/filings/0001104659-26-053548.md) | [2.35](/filings/0001104659-26-089026.md) | [2.30](/filings/0001193125-26-439976.md) |
| Basic EPS | $ per share | not reported | [1.51](/filings/0001558370-25-006162.md) | [1.74](/filings/0001558370-25-009936.md) | [1.88](/filings/0001104659-25-104685.md) | not reported | [0.88](/filings/0001104659-26-053548.md) | [2.12](/filings/0001104659-26-089026.md) | [2.44](/filings/0001193125-26-439976.md) | not reported | [2.29](/filings/0001104659-26-053548.md) | [2.36](/filings/0001104659-26-089026.md) | [2.31](/filings/0001193125-26-439976.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [44.9](/filings/0001558370-25-001274.md) | [45.1](/filings/0001558370-24-006602.md) | [45.5](/filings/0001558370-24-010655.md) | [46.1](/filings/0001558370-24-014094.md) | [46.4](/filings/0001104659-26-017884.md) | [65.1](/filings/0001558370-25-006162.md) | [65.9](/filings/0001558370-25-009936.md) | [66.0](/filings/0001104659-25-104685.md) | [67.2](/filings/0001193125-26-439976.md) | [68.0](/filings/0001104659-26-053548.md) | [68.9](/filings/0001104659-26-089026.md) | [70.4](/filings/0001193125-26-439976.md) |
| Total liabilities | $bn | [39.4](/filings/0001558370-25-001274.md) | [39.6](/filings/0001558370-24-006602.md) | [39.8](/filings/0001558370-24-010655.md) | [40.2](/filings/0001558370-24-014094.md) | [40.5](/filings/0001104659-26-017884.md) | [56.5](/filings/0001558370-25-006162.md) | [57.1](/filings/0001558370-25-009936.md) | [57.0](/filings/0001104659-25-104685.md) | [58.1](/filings/0001193125-26-439976.md) | [58.9](/filings/0001104659-26-053548.md) | [59.8](/filings/0001104659-26-089026.md) | [61.4](/filings/0001193125-26-439976.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.5](/filings/0001104659-26-017884.md) | [5.5](/filings/0001558370-25-009936.md) | [5.7](/filings/0001104659-25-104685.md) | [5.9](/filings/0001104659-25-104685.md) | [5.9](/filings/0001193125-26-439976.md) | [8.6](/filings/0001104659-26-089026.md) | [8.8](/filings/0001193125-26-439976.md) | [9.0](/filings/0001193125-26-439976.md) | [9.1](/filings/0001193125-26-439976.md) | [9.0](/filings/0001104659-26-089026.md) | [9.1](/filings/0001193125-26-439976.md) | [9.0](/filings/0001193125-26-439976.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(274) d](/filings/0001104659-26-017884.md) | [278](/filings/0001558370-25-006162.md) | [127 d](/filings/0001558370-25-009936.md) | [(247) d](/filings/0001104659-25-104685.md) | [354 d](/filings/0001104659-26-017884.md) | [(126)](/filings/0001104659-26-053548.md) | [72.6 d](/filings/0001104659-26-089026.md) | [122 d](/filings/0001193125-26-439976.md) | [232 d](/filings/0001104659-26-017884.md) | [299](/filings/0001104659-26-053548.md) | [274 d](/filings/0001104659-26-089026.md) | [760 d](/filings/0001193125-26-439976.md) |
| Capital expenditure | $m | [12.5 d](/filings/0001104659-26-017884.md) | [5.5](/filings/0001558370-25-006162.md) | [9.5 d](/filings/0001558370-25-009936.md) | [7.4 d](/filings/0001104659-25-104685.md) | [13.4 d](/filings/0001104659-26-017884.md) | [12.8](/filings/0001104659-26-053548.md) | [20.1 d](/filings/0001104659-26-089026.md) | [20.7 d](/filings/0001193125-26-439976.md) | [16.6 d](/filings/0001104659-26-017884.md) | [16.1](/filings/0001104659-26-053548.md) | [13.8 d](/filings/0001104659-26-089026.md) | [20.9 d](/filings/0001193125-26-439976.md) |
| Dividends paid | $m | [39.7 d](/filings/0001104659-26-017884.md) | [40.8](/filings/0001558370-25-006162.md) | [39.7 d](/filings/0001558370-25-009936.md) | [41.2 d](/filings/0001104659-25-104685.md) | [41.2 d](/filings/0001104659-26-017884.md) | [55.8](/filings/0001104659-26-053548.md) | [54.8 d](/filings/0001104659-26-089026.md) | [60.6 d](/filings/0001193125-26-439976.md) | [60.0 d](/filings/0001104659-26-017884.md) | [60.1](/filings/0001104659-26-053548.md) | [58.2 d](/filings/0001104659-26-089026.md) | [64.0 d](/filings/0001193125-26-439976.md) |
| Share repurchases | $m | [8.7 d](/filings/0001104659-26-017884.md) | [15.9](/filings/0001558370-25-006162.md) | [0.1 d](/filings/0001558370-25-009936.md) | [0.6 d](/filings/0001104659-25-104685.md) | [0.1 d](/filings/0001104659-26-017884.md) | [11.2](/filings/0001104659-26-053548.md) | [0.1 d](/filings/0001104659-26-089026.md) | [43.0 d](/filings/0001193125-26-439976.md) | [182 d](/filings/0001104659-26-017884.md) | [160](/filings/0001104659-26-053548.md) | [98.0 d](/filings/0001104659-26-089026.md) | [26.3 d](/filings/0001193125-26-439976.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [76.4](/filings/0001558370-24-006602.md) | [76.4](/filings/0001558370-24-010655.md) | [76.6](/filings/0001558370-24-014094.md) | [76.7](/filings/0001558370-25-006162.md) | [76.6](/filings/0001558370-25-009936.md) | [76.8](/filings/0001104659-25-104685.md) | [102](/filings/0001104659-26-053548.md) | [102](/filings/0001104659-26-089026.md) | [102](/filings/0001193125-26-439976.md) | [98.9](/filings/0001104659-26-053548.md) | [97.7](/filings/0001104659-26-089026.md) | [97.4](/filings/0001193125-26-439976.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 96,680,744 at 2026-10-29, from the cover of the [10-Q filed 2026-10-30](/filings/0001193125-26-439976.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:21 ET. No prices; not investment advice.